ReviewNeurology international2026

Anti-Amyloid Monoclonal Antibodies in Early Alzheimer Disease: Lecanemab and Donanemab.

Ülkü Figen Demir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.